Adherence factors to hypertension treatment in primary care services
DOI:
https://doi.org/10.22267/rus.222401.261Keywords:
Hypertension, Treatment adherence and compliance, Case-control studies, Logistic modelsAbstract
Introduction: In 2008, uncontrolled hypertensive arterial disease (UHAD) was associated with a high cardiovascular mortality that caused 9.4 million deaths and 7% of the disease burden expressed as Disability-Adjusted Life Years (DALYs). The reasons why 50% of the patients treated in primary care facilities in Colombia do not adhere to UHAD treatment are unknown. Objective: To identify factors associated with UHAD treatment adherence in a Public Health Care institution from a Colombian city. Materials and methods: A case-control study with 75 cases and 75 controls randomly selected from a patient database of the arterial hypertension control program. Results: Being older than 50 years was the only factor associated with lack of adherence to treatment. Participants who were 50-59 (OR=3.18; IC95% 1.01-10.00) and 60-69 (OR=3.70; IC95% 1.17-11.60) are less likely to adhere to treatment. Conclusions: Patients who are 50-69 years old had the highest probability of non-adherence to UHAD treatment. Follow-up measures are necessary to improve this figure.
Downloads
Metrics
References
Organización Mundial de la Salud. Es Hora de Actuar: Informe de La Comisión Independiente de Alto Nivel de La OMS Sobre Enfermedades No Transmisibles. Ginebra; 2018. Disponible en: https://apps.who.int/iris/bitstream/handle/10665/272712/9789243514161-spa.pdf?ua=1
Lim SS, Vos T, Flaxman AD, Danaei G, Shibuya K, Adair-Rodahi H, et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. The Lancet. 2012;380(9859):2224-60. DOI: 10.1016/S0140-6736(12)61766-8.
Organización Mundial de la Salud. Informe Sobre La Situación Mundial de Las Enfermedades No Transmisibles 2014: “Cumplimiento de Las Nueve Metas Mundiales Relativas a Las Enfermedades No Transmisibles: Una Responsabilidad Compartida”. Ginebra; 2014. 16 p. Disponible en: https://apps.who.int/iris/bitstream/handle/10665/149296/WHO_NMH_NVI_15.1_spa.pdf?sequence=1
Organización Mundial de la Salud. Información General Sobre a Hipertensión en el Mundo: Una Enfermedad Que Mata en Silencio, Una Crisis de Salud Pública Mundial; 2013. Disponible en: https://apps.who.int/iris/bitstream/handle/10665/87679/WHO_DCO_WHD_2013.2_spa.pdf;jsessionid=79F9E3F46F94214E22710B1701DCD9DA?sequence=1
World Health Organization, World Economic Forum. From Burden to “Best Buys ”: Reducing the Economic Impact of Non-Communicable Diseases in Low- and Middle-Income Countries. Geneva; 2011. Disponible en: https://www.who.int/nmh/publications/best_buys_summary.pdf
Organización Panamericana de la Salud, Universidad de Washington. Las Dimensiones Economicas de Las Enfermedades No Transmisibles En America Latina y El Caribe. Washington D.C: Organización Mundial de la Salud; 2017. Disponible en: http://iris.paho.org/xmlui/bitstream/handle/123456789/33994/9789275319055-spa.pdf?sequence=1&isAllowed=y
Organización Panamericana de la Salud. Salud En Las Américas+, Edición Del 2017. Resumen: Panorama Regional y Perfiles de País. Washington D.C: Organización Mundial de la Salud; 2017. Disponible en: https://www.paho.org/salud-en-las-americas-2017/wp-content/uploads/2017/09/Print-Version-Spanish.pdf
Fondo Colombiano de Enfermedades de Alto Costo. Situación La Enfermedad Renal Crónica, La Hipertensión Arterial y La Diabetes Mellitus En Colombia – 2018. Colombia; 2018. Disponible en: https://cuentadealtocosto.org/site/publicaciones/situacion-de-la-enfermedad-renal-cronica-la-hipertension-arterial-y-la-diabetes-mellitus-en-colombia-2018/
ESE Hospital Santa Margarita. Perfil Epidemiológico de La E.S.E Hospital Santa Margarita. Información Del Departamento de Estadística Relacionado Hipertensión Arterial y Factores Asociados. 2012.
IBM Corporation. IBM SPSS Statistics for Windows, Version 24.0. 2016. Disponible en: http://www-01.ibm.com/support/docview.wss?uid=swg21476197
Schlesselman J. Case-Control Studies: Design, Conduct, Analysis. Oxford University Press; 1982. Disponible en: https://global.oup.com/academic/product/case-control-studies-9780195029338?cc=co&lang=en
Ryan T. Sample Size Determination and Power. En: John Wiley & Sons, Inc. 2013. DOI: 10.1002/9781118439241.
Kleinbaum D, Klein M. Logistic Regression: A Self-Learning Text. 2nd ed. Springer; 2002. DOI: 10.1007/b97379.
Hosmer DW, Lemeshow S. Applied Logistic Regression. 2nd ed. En: John Wiley & Sons, Inc. 2000. DOI: 10.1002/0471722146.
Prga I, Radman I, Leppée M, Culig J, Maric-Bajs M. The role of SMS reminders to increase the hypertensive patients’ adherence to medication: Marcel Leppée. Eur J Public Health. 2016;26(Suppl 1):ckw174.111. DOI: 10.1093/eurpub/ckw174.111.
Teshome DF, Bekele KB, Habitu YA, Gelagay AA. Medication adherence and its associated factors among hypertensive patients attending the Debre Tabor General Hospital, northwest Ethiopia. Integr Blood Press Control. 2017;10:1-7. DOI: 10.2147/IBPC.S128914.
NCD Risk Factor Collaboration (NCD-Risk). Long-term and recent trends in hypertension awareness, treatment, and control in 12 high-income countries: an analysis of 123 nationally representative surveys. The Lancet. 2019;394(10199):639-51. DOI: 10.1016/S0140-6736(19)31145-6.
Sandoval D, Nazzal C, Romero T. Clinical, Socioeconomic, and Psychosocial Factors Associated with Blood Pressure Control and Adherence: Results from a Multidisciplinary Cardiovascular National Program Providing Universal Coverage in a Developing Country. Int J Hypertens. 2018;2018:5634352. DOI: 10.1155/2018/5634352.
Burnier M, Egan BM. Adherence in Hypertension. Circ Res. 2019;124(7):1124-40. DOI: 10.1161/CIRCRESAHA.118.313220.
Woodham N, Taneepanichskul S, Somrongthong R, Auamkul N. Medication adherence and associated factors among elderly hypertension patients with uncontrolled blood pressure in rural area, Northeast Thailand. J Heal Res. 2018;32(6):449-58. DOI: 10.1108/JHR-11-2018-085.
Palafox B, Goryakin Y, Suhrcke M, Balabanova D, Yusuf S, McKeeet M. Can social capital overcome barriers to effective management of hypertension. Study in 17 countries: Martin McKee. Eur J Public Health. 2016;26(Suppl 1):ckw164.068. DOI: 10.1093/eurpub/ckw164.068.
Niessen MAJ, van der Hoeven NV, van den Born B-JH, van Kalken CK, Kraaijenhagen RA. Home blood pressure measurement as a screening tool for hypertension in a web-based worksite health promotion programme. Eur J Public Health. 2014;24(5):776-81. DOI: 10.1093/eurpub/ckt144.
Bergonzoli G. Epidemiologia y Estadística: 1001 Preguntas [Lo Que No Se Atrevio a Preguntar, Pero Siempre Quiso Saber]. IMPRETICS E.I.C.E. 2019.
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 Universidad y Salud
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
